Imagine being able to track your brain health before serious decline sets in, understand your personal risk factors, and intervene early enough to help prevent dementia rather than simply react to it. In this episode of The TechEd Podcast, Matt Kirchner talks with Christin Glorioso, MD, PhD, founder and CEO of NeuroAge Therapeutics, about one of the most intriguing frontiers in health and longevity right now: whether brain aging can actually be measured, influenced, and in some cases pushed b...